News View all news
At emergency meeting, ACIP members could decide who gets first dibs on COVID-19 vaccine
Despite expectations that CDC’s Advisory Committee on Immunization Practices (ACIP) would make its COVID-19 vaccine allocation recommendations once one or more vaccines received FDA emergency use authorization (EUA)—the traditional timeline—the group will vote Tuesday, December 1, on a “Phase 1a” distribution strategy. ACIP convened the 2:00 pm ET December 1 emergency meeting to ensure its advice is available before FDA approves any EUAs; the agency is slated to consider the first application on December 10. U.S. Department of Health and Human Services Secretary Alex Azar has said that Operation Warp Speed will begin shipping COVID-19 vaccines to states within 24 hours of their approval.
Moderna applies for emergency FDA approval for its coronavirus vaccine
Moderna announced Monday it has applied to FDA for emergency use authorization of its candidate COVID-19 vaccine. If approved, the company said, vaccinations could begin in the United States as soon as December 21. Moderna reported that complete data from a large study indicated the vaccine was 94.1% effective, confirming earlier estimates.
Pharmacies add freezers, train staff to handle COVID-19 vaccination drive
Supermarket pharmacies are gearing up to become major providers of COVID-19 vaccinations. Grocery stores say they are well-positioned to provide the vaccines because a large share of the population lives near one of their stores, and their pharmacies regularly offer vaccinations for other illnesses.
Shared clinical decision making important for MenB vaccines
CDC’s Advisory Committee on Immunization Practices (ACIP) has published its 2020 recommendations for meningococcal vaccination, which cover use of the three quadrivalent conjugate vaccines—meningococcal serotypes A, C, W, and Y (MenACWY)—and two available meningococcal serogroup B (MenB) vaccines. The recommendations call on shared clinical decision making for the MenB vaccine for adolescents and young adults ages 16 to 23 years and highlight the importance of these vaccines for patients at increased risk.
November 10, 2020
My statement on the presidential election
I want to share with you my statement on the presidential election. APhA will continue to inform you on our advocacy work before and after the inauguration. The statement: “The American Pharmacists…0 comments
December 1, 2020
American Pharmacists Association Announces Recipients of 2021 Academy Awards
The American Pharmacists Association (APhA) today announced the selection of recipients of the APhA Academy of Pharmacy Practice & Management Awards and APhA Academy of Pharmaceutical Research & Science Awards as part of the 2021 APhA Awards and Honors Program.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.